(+)-dexrazoxane multiple interactions ISO RGD:732704 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of PPP1R15A mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of PPP1R15A protein] CTD PMID:28973540 (+)-pilocarpine increases expression ISO RGD:732704 6480464 Pilocarpine results in increased expression of PPP1R15A protein CTD PMID:16492139 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPP1R15A mRNA] CTD PMID:31150632 (-)-citrinin increases expression ISO RGD:1342864 6480464 Citrinin results in increased expression of PPP1R15A mRNA CTD PMID:21844328 (-)-demecolcine increases expression ISO RGD:1342864 6480464 Demecolcine results in increased expression of PPP1R15A mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1342864 6480464 epigallocatechin gallate results in increased expression of PPP1R15A mRNA CTD PMID:18851785 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1342864 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PPP1R15A mRNA, epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased expression of PPP1R15A mRNA] CTD PMID:22079256 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of PPP1R15A mRNA CTD PMID:20624997 17beta-estradiol increases expression ISO RGD:1342864 6480464 Estradiol results in increased expression of PPP1R15A mRNA CTD PMID:19153601 , PMID:20106945 17beta-estradiol affects expression ISO RGD:732704 6480464 Estradiol affects the expression of PPP1R15A mRNA CTD PMID:15598610 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1342864 6480464 2 more ... CTD PMID:19095052 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:732704 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:732704 6480464 troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732704 6480464 2 more ... CTD PMID:25639565 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732704 6480464 [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PPP1R15A mRNA CTD PMID:15251184 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP1R15A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732704 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R15A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1342864 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP1R15A mRNA CTD PMID:16697128 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732704 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R15A mRNA CTD PMID:15251184 2,4-diaminotoluene increases expression ISO RGD:732704 6480464 2, 4-diaminotoluene results in increased expression of PPP1R15A mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PPP1R15A mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:732704 6480464 Glucosamine results in decreased expression of PPP1R15A mRNA CTD PMID:17178593 2-butoxyethanol increases expression ISO RGD:732704 6480464 n-butoxyethanol results in increased expression of PPP1R15A mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:1342864 6480464 Lactic Acid results in increased expression of PPP1R15A mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1342864 6480464 beta-methylcholine affects the expression of PPP1R15A mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:732704 6480464 tetrabromobisphenol A results in increased expression of PPP1R15A mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:732704 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PPP1R15A mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1342864 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PPP1R15A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:732704 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PPP1R15A exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:732704 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PPP1R15A gene CTD PMID:31683443 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA CTD PMID:24291486 4-hydroxynon-2-enal multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA] CTD PMID:24291486 4-hydroxyphenyl retinamide increases expression ISO RGD:1342864 6480464 Fenretinide results in increased expression of PPP1R15A mRNA CTD PMID:20022965 4-phenylcoumarin increases expression ISO RGD:732704 6480464 4-phenylcoumarin analog results in increased expression of PPP1R15A mRNA CTD PMID:27773722 5-(N,N-hexamethylene)amiloride increases expression ISO RGD:1342864 6480464 5-(N, N-hexamethylene)amiloride results in increased expression of PPP1R15A mRNA CTD PMID:19302589 5-aza-2'-deoxycytidine decreases expression ISO RGD:732704 6480464 Decitabine results in decreased expression of PPP1R15A mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine multiple interactions ISO RGD:732704 6480464 [Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PPP1R15A mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine affects expression ISO RGD:1342864 6480464 Decitabine affects the expression of PPP1R15A mRNA CTD PMID:23300844 5-fluorouracil increases expression ISO RGD:1342864 6480464 Fluorouracil results in increased expression of PPP1R15A mRNA CTD PMID:15331170 , PMID:16709241 5-fluorouracil affects response to substance ISO RGD:1342864 6480464 PPP1R15A protein affects the susceptibility to Fluorouracil CTD PMID:15331170 acetamide increases expression EXP 6480464 acetamide results in increased expression of PPP1R15A mRNA CTD PMID:31881176 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of PPP1R15A mRNA CTD PMID:12800193 acrylamide increases expression ISO RGD:1342864 6480464 Acrylamide results in increased expression of PPP1R15A mRNA CTD PMID:32763439 afimoxifene multiple interactions ISO RGD:1342864 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of PPP1R15A mRNA] CTD PMID:19153601 afimoxifene increases expression ISO RGD:1342864 6480464 afimoxifene results in increased expression of PPP1R15A mRNA CTD PMID:19153601 aflatoxin B1 increases expression ISO RGD:1342864 6480464 Aflatoxin B1 results in increased expression of PPP1R15A mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PPP1R15A mRNA CTD PMID:33354967 aldehydo-D-glucosamine decreases expression ISO RGD:732704 6480464 Glucosamine results in decreased expression of PPP1R15A mRNA CTD PMID:17178593 all-trans-retinal increases expression ISO RGD:1342864 6480464 Retinaldehyde results in increased expression of PPP1R15A mRNA CTD PMID:25331497 all-trans-retinoic acid increases expression ISO RGD:732704 6480464 Tretinoin results in increased expression of PPP1R15A mRNA CTD PMID:22498432 amiodarone increases expression ISO RGD:1342864 6480464 Amiodarone results in increased expression of PPP1R15A mRNA CTD PMID:19774075 , PMID:36586010 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP1R15A mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:732704 6480464 Antimycin A results in increased expression of PPP1R15A mRNA CTD PMID:19304788 antimycin A increases expression ISO RGD:1342864 6480464 Antimycin A results in increased expression of PPP1R15A mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO RGD:1342864 6480464 aristolochic acid I results in increased expression of PPP1R15A mRNA CTD PMID:33212167 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of PPP1R15A mRNA CTD PMID:23123503 arsenite(3-) multiple interactions ISO RGD:1342864 6480464 Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]] more ... CTD PMID:22872678 more ... arsenite(3-) increases expression ISO RGD:1342864 6480464 arsenite results in increased expression of PPP1R15A mRNA, arsenite results in increased expression of PPP1R15A protein CTD PMID:29109149 arsenite(3-) increases expression ISO RGD:732704 6480464 arsenite results in increased expression of PPP1R15A mRNA, arsenite results in increased expression of PPP1R15A protein CTD PMID:29109149 arsenous acid decreases expression ISO RGD:1342864 6480464 Arsenic Trioxide results in decreased expression of PPP1R15A mRNA CTD PMID:22521957 arsenous acid increases expression ISO RGD:1342864 6480464 Arsenic Trioxide results in increased expression of PPP1R15A mRNA CTD PMID:25258189 , PMID:27829220 Azaspiracid increases expression ISO RGD:1342864 6480464 azaspiracid results in increased expression of PPP1R15A mRNA CTD PMID:28939011 azathioprine increases expression ISO RGD:1342864 6480464 Azathioprine results in increased expression of PPP1R15A mRNA CTD PMID:22623647 azoxystrobin decreases expression ISO RGD:1342864 6480464 azoxystrobin results in decreased expression of PPP1R15A mRNA CTD PMID:33512557 belinostat increases expression ISO RGD:732704 6480464 belinostat results in increased expression of PPP1R15A mRNA CTD PMID:29733868 benzene decreases expression ISO RGD:1342864 6480464 Benzene results in decreased expression of PPP1R15A mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:732704 6480464 Benzo(a)pyrene results in increased expression of PPP1R15A mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1342864 6480464 Benzo(a)pyrene results in increased expression of PPP1R15A mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1342864 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:732704 6480464 EIF2S1 protein mutant form inhibits the reaction [7 more ... CTD PMID:30385349 benzo[a]pyrene diol epoxide I increases expression ISO RGD:732704 6480464 7 more ... CTD PMID:30385349 beta-D-glucosamine decreases expression ISO RGD:732704 6480464 Glucosamine results in decreased expression of PPP1R15A mRNA CTD PMID:17178593 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of PPP1R15A mRNA CTD PMID:15651846 bis(2-chloroethyl) sulfide increases expression ISO RGD:1342864 6480464 Mustard Gas results in increased expression of PPP1R15A mRNA CTD PMID:25102026 bisphenol A affects expression ISO RGD:1342864 6480464 bisphenol A affects the expression of PPP1R15A mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A multiple interactions ISO RGD:1342864 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PPP1R15A mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:732704 6480464 bisphenol A results in decreased expression of PPP1R15A mRNA CTD PMID:25594700 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPP1R15A mRNA CTD PMID:25181051 , PMID:32145629 boric acid increases expression ISO RGD:1342864 6480464 boric acid results in increased expression of PPP1R15A mRNA, boric acid results in increased expression of PPP1R15A protein CTD PMID:27587023 boron nitride increases expression ISO RGD:1342864 6480464 boron nitride results in increased expression of PPP1R15A mRNA CTD PMID:30644070 bortezomib increases expression ISO RGD:1342864 6480464 Bortezomib results in increased expression of PPP1R15A mRNA, Bortezomib results in increased expression of PPP1R15A protein CTD PMID:15509775 , PMID:20022965 Brevetoxin B increases expression ISO RGD:1342864 6480464 brevetoxin 2 results in increased expression of PPP1R15A mRNA CTD PMID:20498034 bromoacetate increases expression ISO RGD:1342864 6480464 bromoacetate results in increased expression of PPP1R15A mRNA CTD PMID:19753638 butan-1-ol multiple interactions ISO RGD:1342864 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PPP1R15A mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1342864 6480464 butyraldehyde results in increased expression of PPP1R15A mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:732704 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA] CTD PMID:25451590 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of PPP1R15A mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:1342864 6480464 Cadmium results in increased expression of PPP1R15A mRNA CTD PMID:21120746 more ... cadmium atom multiple interactions ISO RGD:1342864 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R15A mRNA CTD PMID:31738976 cadmium atom decreases expression ISO RGD:732704 6480464 Cadmium results in decreased expression of PPP1R15A mRNA CTD PMID:23358151 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PPP1R15A mRNA CTD PMID:19010381 , PMID:22110744 cadmium dichloride multiple interactions ISO RGD:1342864 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R15A mRNA CTD PMID:31738976 cadmium dichloride increases expression ISO RGD:1342864 6480464 Cadmium Chloride results in increased expression of PPP1R15A mRNA CTD PMID:19013231 more ... Calcimycin increases expression ISO RGD:732704 6480464 Calcimycin results in increased expression of PPP1R15A mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:732704 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA] CTD PMID:25451590 calcium atom multiple interactions EXP 6480464 [Egtazic Acid co-treated with Calcium deficiency] results in increased expression of PPP1R15A mRNA CTD PMID:9878749 calcium(0) multiple interactions EXP 6480464 [Egtazic Acid co-treated with Calcium deficiency] results in increased expression of PPP1R15A mRNA CTD PMID:9878749 cannabidiol increases expression ISO RGD:732704 6480464 Cannabidiol results in increased expression of PPP1R15A mRNA CTD PMID:21542829 cannabidiol increases expression ISO RGD:1342864 6480464 Cannabidiol results in increased expression of PPP1R15A mRNA CTD PMID:26504004 more ... cannabidiol multiple interactions ISO RGD:1342864 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of PPP1R15A mRNA CTD PMID:26504004 carbamazepine affects expression ISO RGD:1342864 6480464 Carbamazepine affects the expression of PPP1R15A mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube decreases expression ISO RGD:732704 6480464 Nanotubes, Carbon results in decreased expression of PPP1R15A mRNA CTD PMID:25554681 carbonyl cyanide p-trifluoromethoxyphenylhydrazone multiple interactions ISO RGD:1342864 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone promotes the reaction [TARDBP protein binds to PPP1R15A protein] CTD PMID:29109149 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of PPP1R15A mRNA CTD PMID:18500788 chloroacetaldehyde affects expression ISO RGD:1342864 6480464 chloroacetaldehyde affects the expression of PPP1R15A mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1342864 6480464 chloropicrin results in increased expression of PPP1R15A mRNA CTD PMID:26352163 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of PPP1R15A mRNA CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:732704 6480464 Chlorpyrifos results in increased expression of PPP1R15A mRNA CTD PMID:32715474 cidofovir anhydrous increases expression ISO RGD:1342864 6480464 Cidofovir results in increased expression of PPP1R15A mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:732704 6480464 Cisplatin results in decreased expression of PPP1R15A mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:1342864 6480464 Cisplatin results in increased expression of PPP1R15A mRNA CTD PMID:27594783 cisplatin affects expression ISO RGD:1342864 6480464 Cisplatin affects the expression of PPP1R15A mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1342864 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PPP1R15A mRNA more ... CTD PMID:21858171 more ... clodronic acid decreases expression ISO RGD:1342864 6480464 Clodronic Acid results in decreased expression of PPP1R15A mRNA CTD PMID:25596134 clofibrate multiple interactions ISO RGD:732704 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PPP1R15A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PPP1R15A mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:732704 6480464 Clofibrate results in decreased expression of PPP1R15A mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1342864 6480464 cobaltous chloride results in increased expression of PPP1R15A mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of PPP1R15A mRNA CTD PMID:24386269 cocaine increases expression EXP 6480464 Cocaine results in increased expression of PPP1R15A mRNA CTD PMID:23644055 copper atom multiple interactions ISO RGD:1342864 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R15A mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO RGD:1342864 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R15A mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate increases expression ISO RGD:1342864 6480464 Copper Sulfate results in increased expression of PPP1R15A mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1342864 6480464 Coumestrol results in decreased expression of PPP1R15A mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1342864 6480464 Asbestos, Crocidolite results in increased expression of PPP1R15A mRNA CTD PMID:18687144 crotonaldehyde increases expression ISO RGD:1342864 6480464 2-butenal results in increased expression of PPP1R15A mRNA CTD PMID:20471460 cycloheximide decreases expression ISO RGD:1342864 6480464 Cycloheximide results in decreased expression of PPP1R15A protein CTD PMID:29109149 cycloheximide multiple interactions ISO RGD:1342864 6480464 arsenite inhibits the reaction [Cycloheximide results in decreased expression of PPP1R15A protein] more ... CTD PMID:29109149 cyclosporin A increases expression ISO RGD:732704 6480464 Cyclosporine results in increased expression of PPP1R15A mRNA CTD PMID:19770486 , PMID:23958496 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of PPP1R15A mRNA CTD PMID:25596134 cyclosporin A increases expression ISO RGD:1342864 6480464 Cyclosporine results in increased expression of PPP1R15A mRNA CTD PMID:20106945 more ... desipramine increases expression EXP 6480464 Desipramine results in increased expression of PPP1R15A protein CTD PMID:20549303 dexamethasone multiple interactions ISO RGD:1342864 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PPP1R15A mRNA CTD PMID:28628672 diallyl trisulfide increases expression ISO RGD:1342864 6480464 diallyl trisulfide results in increased expression of PPP1R15A mRNA CTD PMID:34995734 diarsenic trioxide decreases expression ISO RGD:1342864 6480464 Arsenic Trioxide results in decreased expression of PPP1R15A mRNA CTD PMID:22521957 diarsenic trioxide increases expression ISO RGD:1342864 6480464 Arsenic Trioxide results in increased expression of PPP1R15A mRNA CTD PMID:25258189 , PMID:27829220 diazinon increases methylation ISO RGD:1342864 6480464 Diazinon results in increased methylation of PPP1R15A gene CTD PMID:22964155 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PPP1R15A mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:732704 6480464 Dibutyl Phthalate results in increased expression of PPP1R15A mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:1342864 6480464 Diclofenac affects the expression of PPP1R15A mRNA CTD PMID:24752500 diclofenac decreases expression ISO RGD:732704 6480464 Diclofenac results in decreased expression of PPP1R15A mRNA CTD PMID:35537566 Didecyldimethylammonium increases expression ISO RGD:1342864 6480464 didecyldimethylammonium results in increased expression of PPP1R15A mRNA CTD PMID:32763356 dieldrin increases expression ISO RGD:1342864 6480464 Dieldrin results in increased expression of PPP1R15A mRNA CTD PMID:31068361 dinophysistoxin 1 increases expression ISO RGD:1342864 6480464 dinophysistoxin 1 results in increased expression of PPP1R15A mRNA CTD PMID:28939011 dioxygen increases expression ISO RGD:1342864 6480464 Oxygen deficiency results in increased expression of PPP1R15A mRNA CTD PMID:17914565 , PMID:25596134 dioxygen multiple interactions ISO RGD:732704 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R15A mRNA CTD PMID:30529165 diquat increases expression ISO RGD:1342864 6480464 Diquat results in increased expression of PPP1R15A mRNA CTD PMID:21172416 diquat increases expression ISO RGD:732704 6480464 Diquat results in increased expression of PPP1R15A mRNA CTD PMID:36851058 disodium selenite increases expression ISO RGD:1342864 6480464 Sodium Selenite results in increased expression of PPP1R15A mRNA CTD PMID:24383545 , PMID:28161410 disulfiram multiple interactions ISO RGD:1342864 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R15A mRNA CTD PMID:24690739 diuron decreases expression ISO RGD:1342864 6480464 Diuron results in decreased expression of PPP1R15A mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:1342864 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of PPP1R15A mRNA] CTD PMID:27181935 doxorubicin increases expression ISO RGD:1342864 6480464 Doxorubicin results in increased expression of PPP1R15A mRNA CTD PMID:36634904 doxorubicin multiple interactions ISO RGD:1342864 6480464 [TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of PPP1R15A mRNA CTD PMID:36634904 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PPP1R15A mRNA CTD PMID:27181935 elesclomol increases expression ISO RGD:1342864 6480464 elesclomol results in increased expression of PPP1R15A mRNA CTD PMID:18723479 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PPP1R15A mRNA CTD PMID:29391264 , PMID:31464424 ethanol multiple interactions ISO RGD:1342864 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PPP1R15A mRNA CTD PMID:29432896 ethyl methanesulfonate increases expression ISO RGD:1342864 6480464 Ethyl Methanesulfonate results in increased expression of PPP1R15A mRNA CTD PMID:23649840 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 [Egtazic Acid co-treated with Calcium deficiency] results in increased expression of PPP1R15A mRNA CTD PMID:9878749 fenofibrate increases expression ISO RGD:1342864 6480464 Fenofibrate results in increased expression of PPP1R15A mRNA CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of PPP1R15A mRNA CTD PMID:25596134 fenthion increases expression ISO RGD:1342864 6480464 Fenthion results in increased expression of PPP1R15A mRNA CTD PMID:21538558 ferric oxide decreases expression ISO RGD:732704 6480464 ferric oxide analog results in decreased expression of PPP1R15A mRNA CTD PMID:24525745 fluoranthene multiple interactions ISO RGD:732704 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPP1R15A mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PPP1R15A mRNA CTD PMID:24793618 fluvastatin multiple interactions ISO RGD:1342864 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of PPP1R15A mRNA CTD PMID:16996129 folic acid multiple interactions ISO RGD:1342864 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of PPP1R15A mRNA CTD PMID:24657277 formaldehyde increases expression ISO RGD:1342864 6480464 Formaldehyde results in increased expression of PPP1R15A mRNA CTD PMID:17938736 more ... furan decreases expression EXP 6480464 furan results in decreased expression of PPP1R15A mRNA CTD PMID:26194646 gemcitabine increases expression ISO RGD:1342864 6480464 Gemcitabine results in increased expression of PPP1R15A mRNA CTD PMID:17039268 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PPP1R15A mRNA CTD PMID:33387578 gliotoxin increases expression EXP 6480464 Gliotoxin results in increased expression of PPP1R15A mRNA CTD PMID:18346771 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PPP1R15A mRNA CTD PMID:24915197 hydrogen peroxide increases expression ISO RGD:1342864 6480464 Hydrogen Peroxide results in increased expression of PPP1R15A CTD PMID:18687144 hydrogen peroxide affects expression ISO RGD:1342864 6480464 Hydrogen Peroxide affects the expression of PPP1R15A mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1342864 6480464 hydroquinone results in increased expression of PPP1R15A mRNA CTD PMID:31256213 ibuprofen increases expression ISO RGD:1342864 6480464 Ibuprofen results in increased expression of PPP1R15A mRNA CTD PMID:25596134 idarubicin increases expression ISO RGD:732704 6480464 Idarubicin results in increased expression of PPP1R15A mRNA, Idarubicin results in increased expression of PPP1R15A protein CTD PMID:28973540 idarubicin multiple interactions ISO RGD:732704 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of PPP1R15A mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of PPP1R15A protein] CTD PMID:28973540 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of PPP1R15A mRNA CTD PMID:16184411 indometacin multiple interactions ISO RGD:1342864 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PPP1R15A mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:732704 6480464 Isoproterenol results in increased expression of PPP1R15A mRNA CTD PMID:20003209 L-glutamine increases expression EXP 6480464 Glutamine deficiency results in increased expression of PPP1R15A mRNA CTD PMID:23123503 L-serine decreases expression ISO RGD:1342864 6480464 Serine results in decreased expression of PPP1R15A mRNA CTD PMID:29098664 lactacystin increases expression ISO RGD:1342864 6480464 lactacystin results in increased expression of PPP1R15A mRNA CTD PMID:19135031 leflunomide increases expression ISO RGD:1342864 6480464 leflunomide results in increased expression of PPP1R15A mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1342864 6480464 licochalcone B results in increased expression of PPP1R15A mRNA CTD PMID:33647349 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PPP1R15A mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of PPP1R15A mRNA] CTD PMID:16415329 menadione affects expression ISO RGD:1342864 6480464 Vitamin K 3 affects the expression of PPP1R15A mRNA CTD PMID:20044591 mercury atom decreases expression ISO RGD:1342864 6480464 Mercury results in decreased expression of PPP1R15A mRNA CTD PMID:16823088 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of PPP1R15A mRNA CTD PMID:16507785 mercury(0) decreases expression ISO RGD:1342864 6480464 Mercury results in decreased expression of PPP1R15A mRNA CTD PMID:16823088 metacetamol increases expression ISO RGD:732704 6480464 3-hydroxyacetanilide results in increased expression of PPP1R15A mRNA CTD PMID:18544908 metformin increases expression EXP 6480464 Metformin results in increased expression of PPP1R15A mRNA CTD PMID:25596134 metformin increases expression ISO RGD:1342864 6480464 Metformin results in increased expression of PPP1R15A mRNA CTD PMID:25596134 methamphetamine multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of PPP1R15A mRNA] CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PPP1R15A mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PPP1R15A mRNA CTD PMID:16393664 more ... methotrexate multiple interactions ISO RGD:1342864 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of PPP1R15A mRNA CTD PMID:24657277 methotrexate increases expression ISO RGD:1342864 6480464 Methotrexate results in increased expression of PPP1R15A mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:1342864 6480464 Methyl Methanesulfonate results in increased expression of PPP1R15A mRNA CTD PMID:23649840 Methylazoxymethanol acetate decreases expression EXP 6480464 Methylazoxymethanol Acetate results in decreased expression of PPP1R15A mRNA CTD PMID:28349193 methylisothiazolinone increases expression ISO RGD:1342864 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPP1R15A mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1342864 6480464 methylmercuric chloride results in increased expression of PPP1R15A mRNA CTD PMID:28001369 methylparaben increases expression ISO RGD:1342864 6480464 methylparaben results in increased expression of PPP1R15A mRNA CTD PMID:31745603 methylseleninic acid increases expression ISO RGD:1342864 6480464 methylselenic acid results in increased expression of PPP1R15A mRNA CTD PMID:28161410 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PPP1R15A mRNA CTD PMID:16809437 myristicin decreases expression ISO RGD:1342864 6480464 myristicin results in decreased expression of PPP1R15A mRNA CTD PMID:24792648 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA] CTD PMID:24291486 N-acetyl-L-cysteine multiple interactions ISO RGD:1342864 6480464 Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]] CTD PMID:29109149 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:732704 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PPP1R15A mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1342864 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide results in decreased expression of PPP1R15A protein] CTD PMID:29109149 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1342864 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PPP1R15A mRNA CTD PMID:19135031 N-methyl-4-phenylpyridinium increases expression ISO RGD:732704 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PPP1R15A mRNA CTD PMID:22776087 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PPP1R15A mRNA CTD PMID:16026605 N-methyl-4-phenylpyridinium increases expression ISO RGD:1342864 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PPP1R15A mRNA, 1-Methyl-4-phenylpyridinium results in increased expression of PPP1R15A protein CTD PMID:19135031 , PMID:24810058 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of PPP1R15A mRNA] CTD PMID:16415329 nickel sulfate increases expression ISO RGD:1342864 6480464 nickel sulfate results in increased expression of PPP1R15A mRNA CTD PMID:18651567 niclosamide increases expression ISO RGD:1342864 6480464 Niclosamide results in increased expression of PPP1R15A mRNA CTD PMID:36318118 Nodularin increases expression ISO RGD:1342864 6480464 nodularin results in increased expression of PPP1R15A mRNA CTD PMID:27061667 organoselenium compound multiple interactions ISO RGD:1342864 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of PPP1R15A mRNA CTD PMID:25167922 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP1R15A mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:732704 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PPP1R15A mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PPP1R15A mRNA CTD PMID:34911549 p-chloromercuribenzoic acid multiple interactions ISO RGD:1342864 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R15A mRNA CTD PMID:27188386 p-menthan-3-ol increases expression ISO RGD:1342864 6480464 Menthol results in increased expression of PPP1R15A mRNA CTD PMID:26760959 paracetamol multiple interactions ISO RGD:732704 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PPP1R15A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PPP1R15A mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1342864 6480464 Acetaminophen results in increased expression of PPP1R15A mRNA CTD PMID:21420995 , PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PPP1R15A mRNA CTD PMID:18346771 , PMID:33387578 paracetamol affects expression ISO RGD:732704 6480464 Acetaminophen affects the expression of PPP1R15A mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:732704 6480464 Acetaminophen results in increased expression of PPP1R15A mRNA CTD PMID:11264010 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of PPP1R15A mRNA CTD PMID:32680482 paraquat increases expression ISO RGD:1342864 6480464 Paraquat results in increased expression of PPP1R15A mRNA CTD PMID:35182771 patulin increases expression ISO RGD:1342864 6480464 Patulin results in increased expression of PPP1R15A mRNA, Patulin results in increased expression of PPP1R15A protein CTD PMID:21844328 , PMID:25577197 pentanal increases expression ISO RGD:1342864 6480464 pentanal results in increased expression of PPP1R15A mRNA CTD PMID:26079696 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PPP1R15A mRNA CTD PMID:19162173 , PMID:21318169 perfluorooctanoic acid increases expression ISO RGD:1342864 6480464 perfluorooctanoic acid results in increased expression of PPP1R15A mRNA CTD PMID:36326898 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of PPP1R15A mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:732704 6480464 Phenobarbital results in decreased expression of PPP1R15A mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:1342864 6480464 Phenobarbital affects the expression of PPP1R15A mRNA CTD PMID:19159669 phenobarbital increases expression ISO RGD:732704 6480464 Phenobarbital results in increased expression of PPP1R15A mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO RGD:732704 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPP1R15A mRNA] CTD PMID:19482888 phenylmercury acetate multiple interactions ISO RGD:1342864 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R15A mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:1342864 6480464 Tetradecanoylphorbol Acetate results in increased expression of PPP1R15A mRNA CTD PMID:31068361 picoxystrobin decreases expression ISO RGD:1342864 6480464 picoxystrobin results in decreased expression of PPP1R15A mRNA CTD PMID:33512557 pirinixic acid decreases expression ISO RGD:732704 6480464 pirinixic acid results in decreased expression of PPP1R15A mRNA CTD PMID:20059764 pirinixic acid multiple interactions ISO RGD:732704 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of PPP1R15A mRNA] CTD PMID:20059764 piroxicam multiple interactions ISO RGD:1342864 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of PPP1R15A mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1342864 6480464 Piroxicam results in decreased expression of PPP1R15A mRNA CTD PMID:21858171 potassium bromate decreases methylation ISO RGD:1342864 6480464 potassium bromate results in decreased methylation of PPP1R15A promoter CTD PMID:30559759 potassium chromate multiple interactions ISO RGD:1342864 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PPP1R15A mRNA, epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased expression of PPP1R15A mRNA] CTD PMID:22079256 potassium chromate increases expression ISO RGD:1342864 6480464 potassium chromate(VI) results in increased expression of PPP1R15A mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732704 6480464 Pregnenolone Carbonitrile results in increased expression of PPP1R15A mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1342864 6480464 Progesterone results in increased expression of PPP1R15A mRNA CTD PMID:18037150 quercetin increases expression ISO RGD:1342864 6480464 Quercetin results in increased expression of PPP1R15A mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:1342864 6480464 Quercetin inhibits the reaction [zearalenol results in increased expression of PPP1R15A protein] CTD PMID:26584763 rac-lactic acid increases expression ISO RGD:1342864 6480464 Lactic Acid results in increased expression of PPP1R15A mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:1342864 6480464 Raloxifene Hydrochloride results in increased expression of PPP1R15A mRNA CTD PMID:16497877 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of PPP1R15A mRNA CTD PMID:16079270 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of PPP1R15A mRNA] CTD PMID:16415329 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of PPP1R15A mRNA CTD PMID:33775663 resveratrol multiple interactions ISO RGD:1342864 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PPP1R15A mRNA CTD PMID:23557933 rotenone increases expression ISO RGD:732704 6480464 Rotenone results in increased expression of PPP1R15A mRNA CTD PMID:19304788 , PMID:23186747 rotenone increases expression ISO RGD:1342864 6480464 Rotenone results in increased expression of PPP1R15A mRNA CTD PMID:36586010 rotenone decreases expression ISO RGD:1342864 6480464 Rotenone results in decreased expression of PPP1R15A mRNA CTD PMID:33512557 salubrinal increases expression ISO RGD:1342864 6480464 salubrinal results in increased expression of PPP1R15A protein CTD PMID:23690448 salubrinal multiple interactions ISO RGD:732704 6480464 [salubrinal results in decreased activity of [PPP1CC protein binds to PPP1R15A protein]] which affects the localization of CALR protein CTD PMID:17187072 SB 431542 multiple interactions ISO RGD:1342864 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of PPP1R15A mRNA] CTD PMID:19564919 Se-methyl-L-selenocysteine increases expression ISO RGD:732704 6480464 selenomethylselenocysteine results in increased expression of PPP1R15A mRNA CTD PMID:10656618 Se-methylselenocysteine increases expression ISO RGD:732704 6480464 selenomethylselenocysteine results in increased expression of PPP1R15A mRNA CTD PMID:10656618 sertraline increases expression ISO RGD:1342864 6480464 Sertraline results in increased expression of PPP1R15A mRNA CTD PMID:24865413 Shikonin multiple interactions ISO RGD:732704 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA] CTD PMID:25451590 silicon dioxide increases expression ISO RGD:1342864 6480464 Silicon Dioxide analog results in increased expression of PPP1R15A mRNA, Silicon Dioxide results in increased expression of PPP1R15A mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:732704 6480464 Silicon Dioxide results in increased expression of PPP1R15A mRNA CTD PMID:19073995 , PMID:33720480 silver atom increases expression ISO RGD:732704 6480464 Silver results in increased expression of PPP1R15A mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:1342864 6480464 Silver results in increased expression of PPP1R15A mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:732704 6480464 Silver results in increased expression of PPP1R15A mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1342864 6480464 Silver results in increased expression of PPP1R15A mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:1342864 6480464 sodium arsenite results in increased expression of PPP1R15A mRNA CTD PMID:23876855 more ... sodium arsenite decreases expression ISO RGD:1342864 6480464 sodium arsenite results in decreased expression of PPP1R15A mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:732704 6480464 sodium arsenite results in increased expression of PPP1R15A mRNA, sodium arsenite results in increased expression of PPP1R15A protein CTD PMID:12606582 more ... Soman increases expression EXP 6480464 Soman results in increased expression of PPP1R15A mRNA CTD PMID:19281266 sorafenib increases expression ISO RGD:1342864 6480464 sorafenib results in increased expression of PPP1R15A protein CTD PMID:17548474 tacrolimus hydrate increases expression ISO RGD:732704 6480464 Tacrolimus results in increased expression of PPP1R15A mRNA CTD PMID:23958496 tamibarotene increases expression ISO RGD:1342864 6480464 tamibarotene results in increased expression of PPP1R15A mRNA CTD PMID:17229644 temozolomide increases expression ISO RGD:1342864 6480464 Temozolomide results in increased expression of PPP1R15A mRNA CTD PMID:31758290 terbufos increases expression ISO RGD:1342864 6480464 terbufos results in increased expression of PPP1R15A mRNA CTD PMID:21538558 tert-butyl hydroperoxide increases expression ISO RGD:1342864 6480464 tert-Butylhydroperoxide results in increased expression of PPP1R15A mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:732704 6480464 Testosterone results in increased expression of PPP1R15A mRNA CTD PMID:20403060 tetrachloroethene increases expression ISO RGD:732704 6480464 Tetrachloroethylene results in increased expression of PPP1R15A mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PPP1R15A mRNA CTD PMID:18346771 , PMID:31150632 tetrachloromethane increases expression ISO RGD:732704 6480464 Carbon Tetrachloride results in increased expression of PPP1R15A mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPP1R15A mRNA] CTD PMID:31150632 thalidomide increases expression ISO RGD:1342864 6480464 Thalidomide analog results in increased expression of PPP1R15A mRNA CTD PMID:20525221 thapsigargin multiple interactions ISO RGD:1342864 6480464 [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA, Cycloheximide inhibits the reaction [Thapsigargin results in increased expression of PPP1R15A protein] CTD PMID:17283163 , PMID:29109149 thapsigargin multiple interactions ISO RGD:732704 6480464 EIF2S1 protein modified form affects the reaction [Thapsigargin results in increased expression of PPP1R15A mRNA], EIF2S1 protein modified form affects the reaction [Thapsigargin results in increased expression of PPP1R15A protein] CTD PMID:29109149 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of PPP1R15A mRNA CTD PMID:9878749 thapsigargin increases expression ISO RGD:1342864 6480464 Thapsigargin results in increased expression of PPP1R15A mRNA, Thapsigargin results in increased expression of PPP1R15A protein CTD PMID:19135031 more ... thapsigargin increases expression ISO RGD:732704 6480464 Thapsigargin results in increased expression of PPP1R15A mRNA, Thapsigargin results in increased expression of PPP1R15A protein CTD PMID:12606582 , PMID:29109149 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PPP1R15A mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:732704 6480464 titanium dioxide results in decreased expression of PPP1R15A mRNA CTD PMID:23409001 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PPP1R15A mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP1R15A mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPP1R15A mRNA CTD PMID:33387578 triptonide increases expression ISO RGD:732704 6480464 triptonide results in increased expression of PPP1R15A mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1342864 6480464 troglitazone results in increased expression of PPP1R15A mRNA CTD PMID:19140230 troglitazone decreases expression ISO RGD:732704 6480464 troglitazone results in decreased expression of PPP1R15A mRNA CTD PMID:28973697 trovafloxacin multiple interactions ISO RGD:732704 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PPP1R15A mRNA CTD PMID:18930950 tungsten decreases expression ISO RGD:732704 6480464 Tungsten results in decreased expression of PPP1R15A mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:1342864 6480464 Tunicamycin results in increased expression of PPP1R15A mRNA CTD PMID:22378314 more ... tunicamycin multiple interactions ISO RGD:1342864 6480464 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of PPP1R15A mRNA] CTD PMID:23741617 tunicamycin multiple interactions ISO RGD:732704 6480464 [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of PPP1R15A mRNA CTD PMID:29793971 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of PPP1R15A mRNA, Tunicamycin results in increased expression of PPP1R15A protein CTD PMID:24291486 , PMID:24892553 urethane increases expression ISO RGD:1342864 6480464 Urethane results in increased expression of PPP1R15A mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1342864 6480464 Valproic Acid results in increased methylation of PPP1R15A gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1342864 6480464 Valproic Acid results in increased expression of PPP1R15A mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1342864 6480464 Valproic Acid affects the expression of PPP1R15A mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PPP1R15A mRNA CTD PMID:21318169 vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of PPP1R15A mRNA CTD PMID:20624997 vincristine increases expression EXP 6480464 Vincristine results in increased expression of PPP1R15A mRNA CTD PMID:20624997 vincristine increases expression ISO RGD:1342864 6480464 Vincristine results in increased expression of PPP1R15A mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:1342864 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPP1R15A mRNA CTD PMID:18593933 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of PPP1R15A mRNA CTD PMID:19111725 zinc(0) multiple interactions ISO RGD:1342864 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPP1R15A mRNA CTD PMID:18593933 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of PPP1R15A mRNA CTD PMID:19111725 zoledronic acid multiple interactions ISO RGD:1342864 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of PPP1R15A mRNA CTD PMID:16996129 zoledronic acid increases expression ISO RGD:1342864 6480464 zoledronic acid results in increased expression of PPP1R15A mRNA CTD PMID:20977926